Share
Ipek Erdogan-Trinkaus
Eton Pharmaceuticals, Inc., a pharmaceutical company dedicated to developing and commercializing treatments for rare diseases, announced the appointment of Ipek Erdogan-Trinkaus as Chief Commercial Officer (CCO).
Ms. Erdogan-Trinkaus brings extensive commercial expertise in the pharmaceutical industry, with leadership experience spanning sales, marketing, and strategic growth initiatives. She has a strong background in pediatric endocrinology, having played a key role at Tolmar Pharmaceuticals in launching the rare pediatric endocrinology product FENSOLVI®. During her tenure, she held multiple leadership positions, culminating in her role as General Manager of the Pediatric Endocrinology business unit.
In addition to her pharmaceutical experience, Ms. Erdogan-Trinkaus has a history of driving business growth in the health and wellness sector. Before joining Eton, she served as Chief Commercial Officer at milkadamia™, a leading plant-based food and beverage brand, where she led brand-building efforts and implemented long-term growth strategies. Her previous roles include leadership positions at Ameda, Inc., Mead Johnson Nutrition, and Abbott Nutrition.
Ms. Erdogan-Trinkaus holds a Bachelor of Science in Business Administration from Middle East Technical University, Turkey’s top-ranked university, and an MBA from The Ohio State University’s Fisher College of Business.
